Tag: Continuous Glucose Monitor (CGM)
Ascensia receives iCGM designation for Eversense
May 1, 2024HME News Staff
PARSIPPANY, N.J. – Ascensia Diabetes Care and Senseonics Holdings have received an integrated CGM designation from the U.S. Food and Drug Administration. The designation indicates that the Eversense iCGM product can integrate with compatible medical devices, including insulin pumps. “Managing diabetes is all about personal choice and finding the options that best support an individual to live a healthier, less interrupted life,” said Brian Hansen, president of CGM at Ascensia. “For...
In brief: Walgreens creates new pharmacy biz, CQRC contributes to hearing, OIG contacts CGM providers
May 1, 2024HME News Staff
DEERFIELD, Ill. – AllianceRx Walgreens Pharmacy will become Walgreens Specialty Pharmacy effective Aug.1, 2024, in a move that Walgreens says will expand care for patients with complex, chronic conditions.
Walgreens will now have nearly 300 community-based specialty pharmacies nationwide, with more than 1,500 specialty-trained pharmacists, 5,000 patient advocacy support team members and dedicated Specialty360 teams that support all specialty conditions and therapies.
“With...
OIG contacts providers for CGM cost study
April 30, 2024HME News Staff
WASHINGTON – The Office of Inspector General has begun sending emails and letters to a select group of continuous glucose monitor (CGM) suppliers as part of an evaluation for its study "Medicare Payments Compared to the Prices Available to Consumers and Suppliers for Continuous Glucose Monitors and Sensors," AAHomecare reports.
This study aims to determine the cost-effectiveness of Medicare payments in comparison to the supplier’s acquisition costs and other prices available...
Health care goes OTC
April 26, 2024Theresa Flaherty, Managing Editor
As is par for the course these days, my inbox this month has been filled with diabetes tech announcements: Edgepark is adding a new insulin delivery system to its portfolio, Insulet’s Omnipod is fueling growth and Ascensia is expanding access to its Eversense device by extending its PASS program, which offers a substantial discount for users.
That last one is key: All the technology in the world won’t help if it’s too expensive for people to acquire. And this stuff is expensive...
Ascensia extends PASS program
March 14, 2024HME News Staff
PARSIPPANY, N.J. – Ascensia Diabetes Care and Senseonics Holdings will extend the Eversense Payment Assistance and Simple Savings (PASS) Program. Designed to help people in the U.S. access the Eversense E3 CGM System more affordably, the program offers major savings for eligible individuals looking to experience the unique benefits of the only long-term CGM system available. Eligible individuals will pay only $99 out of pocket for an unlimited number of six-month Eversense E3 systems under...
Dexcom to introduce OTC glucose sensor
March 6, 2024HME News Staff
SAN DIEGO – Dexcom has received clearance from the U.S. Food and Drug Administration for its Stelo by Dexcom, a continuous glucose monitor that will be available for people with Type 2 diabetes without a prescription. “Dexcom continues to lead innovation in the CGM market, with a long list of first-in-market advances,” said Jake Leach, executive vice president and COO. “Dexcom was the first to connect CGM to multiple insulin delivery devices, the first to connect CGM to a...
Active medical supplies market full of evolution
March 1, 2024John Andrews
For sheer volume, the medical supplies category tops the HME industry in terms of breadth and depth of product options. It encompasses several categories, including urology, ostomy, wound care, enteral nutrition, incontinence, breast pumps, CPAP and diabetes management supplies, including continuous glucose monitors.
While this may seem unwieldy, it represents a smorgasbord of business options and opportunities for HME providers, manufacturers in the field say.
“The medical...
Know Labs unveils non-invasive CGM
February 29, 2024HME News Staff
SEATTLE – Know Labs, an emerging developer of non-invasive medical diagnostic technology, has unveiled KnowU, a wearable non-invasive continuous glucose monitor (CGM), the result of an accelerated development process over the last eight months. The KnowU incorporates the sensor that the company plans to submit to the U.S. Food and Drug Administration for clearance. “The prevalence of diabetes is growing globally at an alarming rate,” said Ron Erickson, CEO and chairman. “Millions...
Ascensia announces coverage expansion for CGM system
February 12, 2024HME News Staff
PARSIPPANY, N.J. – Ascensia Diabetes Care and Senseonics Holdings have announced that Medicare has significantly expanded access to the Eversense E3 CGM System with the implementation of local coverage determinations that provide access to implantable CGM for basal-only patients. Medicare coverage has been expanded for implantable CGMs to include all people with diabetes using insulin, removing the previous requirement for multiple inulin administrations per day. Coverage has also been updated...
Ascensia names leader for CGM business
February 6, 2024HME News Staff
TOKYO – PHC Holdings Corp., the parent company of Ascensia Diabetes Care, and Senseonics Holdings have announced that diabetes industry veteran Brian Hansen has been appointed to the newly created role of president of CGM at Ascensia Diabetes Care effective today, Feb. 6, 2024. Hansen will be responsible for the global commercialization and growth of the Eversense CGM, which is currently available in the U.S. and select European markets. “Eversense is a game-changer for people with diabetes...